Regardless of differences in health care delivery systems and medication reimbursement plans, the use of osteoporosis medications for the secondary prevention of osteoporotic fracture was low. Adherence to osteoporosis treatment was also suboptimal with the PDC<0.70 in all three countries.

Leave a Reply

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *